FANAPT |
ILOPERIDONE |
HP-873 |
1-[4-[3-[4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1- PIPERIDINYL]PROPOXY]-3-METHOXYPHENYL]ETHANONE |
ILO522 |
4'-{3-[4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)PIPERIDINO]PROPOXY}-3'-METHOXYACETOPHENONE |
pubchem.compound:71360 |
chemidplus:133454-47-4 |
chembl:CHEMBL14376 |
drugbank:04946 |
rxcui:73178 |
Drug Class | antipsychotic agents |
Year of Approval | 2009 |
FDA Approval | approved |
Drug Class | Small molecule |
Drug Indications | antipsychotic agent,atypical |
antagonist (inhibitory) |
Trial Name | iloperidone,Fanapt, Fiapta, Zomaril |
Novel drug target | Established target |
antagonist (inhibitory) |
Novel drug target | Established target |
Trial Name | iloperidone,Fanapt, Fiapta, Zomaril |
antagonist (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Serotonin 2a (5-HT2a) receptor antagonist |
Novel drug target | Established target |
antagonist (inhibitory) |
Mechanism of Interaction | Dopamine D2 receptor antagonist |
Direct Interaction | yes |
Novel drug target | Established target |
antagonist (inhibitory) |
Novel drug target | Established target |
Trial Name | iloperidone,Fanapt, Fiapta, Zomaril |
antagonist (inhibitory) |
Trial Name | iloperidone,Fanapt, Fiapta, Zomaril |
Novel drug target | Established target |
antagonist (inhibitory) |
Trial Name | iloperidone,Fanapt, Fiapta, Zomaril |
Novel drug target | Established target |
antagonist (inhibitory) |
Trial Name | iloperidone,Fanapt, Fiapta, Zomaril |
Novel drug target | Established target |
antagonist (inhibitory) |
Trial Name | iloperidone,Fanapt, Fiapta, Zomaril |
Novel drug target | Established target |
antagonist (inhibitory) |
Novel drug target | Established target |
Trial Name | iloperidone,Fanapt, Fiapta, Zomaril |
ILOPERIDONE | Primary Drug Name |
Year of Approval | 2009 |
Drug Class | antipsychotic agents |
Drug Indications | antipsychotic agent,atypical |
Drug Class | Small molecule |
FDA Approval | approved |
D0M8VE | TTD Drug ID |